Last reviewed · How we verify
NCT07513051
DIaphragmatic Swing According to Cpap Flow Output in NEOnates (DISCONEO)
NA trial testing CF-CPAP; CF-CPAP; VF-CPAP; VF-CPAP in Neonatal Respiratory Distress in 20 participants. Not yet recruiting.
2 May 2026
Quick facts
| Lead sponsor | Centre Hospitalier Intercommunal Creteil |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 1 May 2026 |
| Primary completion | 2 May 2026 |
| Estimated completion | 2 November 2027 |
| Sites | 1 location across France |
Drugs / interventions tested
- CF-CPAP; CF-CPAP; VF-CPAP; VF-CPAP
- VF-CPAP; VF-CPAP; CF-CPAP; CF-CPAP
- CF-CPAP; VF-CPAP; VF-CPAP; CF-CPAP
- VF-CPAP; CF-CPAP; CF-CPAP; VF-CPAP
Conditions studied
- Neonatal Respiratory Distress — all drugs for Neonatal Respiratory Distress →
Sponsor
Centre Hospitalier Intercommunal Creteil
Who can join
Adults 72 Hours to 10 Weeks, any sex, with Neonatal Respiratory Distress. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The hypothesis behind the study is that the performance of constant flow CPAP (Continuous Positive Airway Pressure) devices (CF-CPAP) is not inferior to that of variable flow CPAP devices (VF-CPAP) in terms of respiratory efforts assessed by swing EAdi (Electrical activity of diaphragm) in a population of premature neonates born ≤ 32 weeks of gestational age.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07513051
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Neonatal Respiratory Distress
Currently open trials in the same condition.
- NCT06572033 — Transference of Established Simulated Skills (TEST) Trial · active not recruiting
Other Centre Hospitalier Intercommunal Creteil trials
Trials by the same sponsor.
- NCT07493785 — Dexmedetomidine for Invasive Ventilation In the NEOnate · Phase 2, PHASE3 · not yet recruiting
- NCT07455942 — Towards an Understanding of Barriers and Delays in the Diagnosis of Anal Cancer · not yet recruiting
- NCT07153367 — Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauter · Phase 2 · recruiting
- NCT06339450 — Real World Environmental Exposure Study With Healthy and Cystic Fibrosis Subjects · NA · not yet recruiting
- NCT07472842 — Study on the Outcomes of Patients Treated in Gynecological Emergency Departments for Pelvic Endometriosis or Suspected P · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07513051 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Intercommunal Creteil
- Last refreshed: 6 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07513051.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing